Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma

Journal of Clinical Oncology

Volumn 16, Issue 9, 1998, Pages 3000-3006

  Sandor, Victor ^b   Stark Vancs, Virginia ^b   Pearson, Deborah ^b   Nussenblat, Richard ^b   Whitcup, Scott M ^b   Brouwers, Pim ^b   Patronas, Nicholas ^b   Heiss, John ^b   Jaffe, Elaine ^b   DeSmet, Marc ^b   Kohler, David ^b   Simon, Richard ^b   Wittes, Robert ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DEXAMETHASONE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; THIOTEPA; VINCRISTINE;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; EYE TUMOR; FEMALE; HUMAN; ILEUS; INTRATHECAL DRUG ADMINISTRATION; LEUKOENCEPHALOPATHY; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEIZURE;

EID: 0031693338     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.9.3000     Document Type: Article

References (21)

1. Eby NL, Grufferman S, Flannelly CM, et al: Increasing incidence of primary brain lymphoma in the US. Cancer 62:2461-2465, 1988
2. Miller DC, Hochberg FH, Harris NL, et al: Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer 74:1383-1397, 1994
3. Gill PS, Levine AM, Meyer PR, et al: Primary central nervous system lymphoma in homosexual men: Clinical, immunological, and pathological features. Am J Med 78:742-748, 1985
4. MacMahon EME, Glass JD, Hayward SD, et al: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338:969-972, 1991
5. Henry JM, Heffner RR, Dillard SH, et al: Primary malignant lymphomas of the central nervous system. Cancer 34:1293-1302, 1974
6. Hochberg FH, Loeffler JS, Prados M: The therapy of primary brain lymphoma. J Neurooncol 10:191-201, 1991
7. Trudeau M, Shepard FA, Blackstein ME, et al: Intraocular lymphoma: Report of three cases and review of the literature. Am J Clin Oncol 11:126-130, 1988
8. Fine HA, Mayer RJ: Primary central nervous system lymphoma. Ann Intern Med 119:1093-1104, 1993
9. Gabbai AA, Hochberg FH, Linggood RM, et al: High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J Neurosurg 70:190-194, 1989
10. DeAngelis LM, Yahalom J, Thaler HT, et al: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10:635-643
11. Schulz C, Scott CTW, Sherman W, et al: Pre-irradiation chemotherapy (CTX) with cytoxan, Adriamycin, vincristine, and dexamethasone for primary central nervous system lymphoma (PCNSL): Initial report of the Radiation Therapy Oncology Group (RTOG) protocol 88-06. J Clin Oncol 14:556-564, 1996
12. Blay JL, Bouhour D, Carrie C, et al: The C5R protocol: A regimen of high-dose chemotherapy and radiotherapy in primary central nervous system lymphoma of patients with no known cause of immunosuppression. Blood 86:2922-2929, 1995
13. Balis FM, Poplack DG: Central nervous system pharmacology of antileukemic drugs. Am J Pediatr Hematol Oncol 11:74-86, 1989
14. Bleyer WA: Methotrexate: Clinical pharmacology, current status and therapeutic guidelines. Cancer Treat Rev 4:87-101, 1977
15. Thall PF, Simon R, Estey E: A new statistical strategy for monitoring safety and efficacy in single-arm clinical trials. J Clin Oncol 14:296-303, 1996
16. Sagerman RH, Cassady JR, Chang CH: Radiation therapy for intracranial lymphoma. Radiology 88:552-559, 1967
17. Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. J Neurosurg 65:600-607, 1987
18. Nelson DF, Martz KJ: Non-Hodgkin's lymphoma of the brain: Can high-dose large-volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 83-15. Int J Radiat Oncol Biol Phys 23:9-16, 1992
19. Skarin AT, Zukerman KS, Pitman SW, et al: High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin's lymphoma including CNS involvement. Blood 50:1039-1047, 1977
20. Neuwelt EA, Goldman DL, Dahlberg SA, et al: Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function. J Clin Oncol 9:1580-1590, 1991
21. Glantz MJ, Hall WA, Cole BF, et al: Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid flow status. Cancer 75:2919-2931, 1995